Kevin Charles Oeffinger, MD, has been named director of the Duke Cancer Supportive Care and Survivorship Center at Duke Cancer Institute. He has also been charged with establishing the Duke Center for Onco-Primary Care, an innovative program within the Duke Cancer Institute, in partnership with the Duke University Health System, that unites cancer specialists and primary care clinicians.
Oeffinger will also accept a faculty appointment in the Department of Medicine, Division of Medical Oncology, with a secondary appointment in the Department of Community and Family Health at Duke Health.
Since 2014 Oeffinger has directed the Cancer Survivorship Center at the Memorial Sloan Kettering Cancer Center (MSKCC). For the past 11 years he has served as director of the Adult Long-Term Follow-Up Program at MSKCC; a program he established to serve the needs of high risk adult survivors of childhood, adolescent and young adult cancer.
Oeffinger received his medical degree from the University of Texas Health Science Center in San Antonio, Texas. For the past four years he was an attending physician in the department of medicine at MSKCC’s Memorial Hospital for Cancer and Allied Diseases, and from 2005 to 2012 was an attending physician in the department of pediatrics.
Oeffinger’s extensive research background includes, most recently, serving as principal investigator of a multi-million dollar grant from the National Cancer Institute for a multi-center study on promoting breast cancer screening in women who survived childhood cancer, as co-investigator and executive committee member for a 26-institution cohort NCI-funded childhood cancer survivor study, and as PI for a study focused on improving outcomes of cancer survivors and mentoring and bridging primary care and oncology.
“Dr. Oeffinger’s training, experience and leadership qualities make him the ideal candidate to lead onco-primary care and survivorship at Duke,” said Michael Kastan, MD, PhD, DCI executive director. “We are thrilled to have attracted him from Memorial Sloan Kettering where patient care and research have been his principle areas of focus. He will be well-equipped to help catalyze culture change among oncologists with respect to referral and care-management patterns.”
In addition to overseeing the Duke Cancer Supportive Care and Survivorship Center’s five current programs—Duke Patient Cancer Support Program, Cancer Survivorship Clinic, Patient Navigation Program, and Tobacco Cessation Program—Oeffinger will also fully develop and lead additional programs within the center that are currently under development, including the Adolescent and Young Adult Oncology Program, Oncology Rehabilitation, Senior Oncology, and Fertility Services and Sexual Health. He will work closely with the Clinical Cancer Genetics Program, led by Noah Kauff, MD, particularly toward a vision of risk-stratified survivorship and onco-primary care.
“The onco-primary initiative is a critical part of the Duke University Health System’s rapid regional expansion of its primary care network,” explained Thomas Owens, MD, chief medical officer, DUHS. “Dr. Oeffinger will help DUHS adapt to and lead cancer health care delivery transformation, addressing quality improvement, improvement in patient-centered care, value-based focus on quality outcomes and lower costs, evidence-based quality improvement in preparation for value-based reimbursement, population health management, improved utilization of palliative and hospice care services and the critical role of primary care in coordination of multi-specialty care across the cancer continuum of care.”
Oeffinger is the recipient of numerous awards, including the Robert Wood Johnson Foundation Generalist Physician Faculty award and the MSKCC Award for Excellence In Mentoring.